Stephen J. Schuster

33.6k citations
376 papers · 12.0k · 3 hit papers · h-index 48

Impact in

  • Oncology top 0.1%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Viral-associated cancers and disorders
    • Lymphoma Diagnosis and Treatment

Papers in

    • CAR-T cell therapy research 161
    • Viral-associated cancers and disorders 33
    • Cancer Immunotherapy and Biomarkers 19
    • Lymphoma Diagnosis and Treatment 189

Stephen J. Schuster

352 papers receiving 11.8k citations

Stephen J. Schuster's Hit Papers

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study 2022 · 275 citations
2750+4+8Years since publication50010001.5k2.0k2.5k

Peers

Stephen J. Schuster
Comparison fields: 5 of 121
  • Oncology 7.7k
  • Pathology and Forensic Medicine 4.3k
  • Genetics 1.8k
  • Immunology 2.6k
  • Hematology 959
Replace Sattva S. Neelapu with:
Sattva S. Neelapu United States
Brian K. Link United States
Arnold S. Freedman United States
Marco Bregni Italy
Izidore S. Lossos United States
John Kuruvilla Canada
Raymond R. Tubbs United States
Adam Bagg United States
Paul J. Kurtin United States
Michael Crump Canada
Stephen J. Schuster relative to Sattva S. Neelapu United States Sattva S. Neelapu's profile →
Citations per field
00.5×1.7×
Sattva S. Neelapu · 1×
Citations per year

Countries citing papers authored by Stephen J. Schuster

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Schuster more than expected).

Fields of papers citing papers by Stephen J. Schuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Schuster. The network helps show where Stephen J. Schuster may publish in the future.

Co-authors

The 25 scholars most cited alongside Stephen J. Schuster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stephen J. Schuster Line = papers co-authored together Stephen J. Schuster links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 376 papers — load more, or switch the sort, to bring in the rest.

#Work
1
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Hit paper breakdown →
20142687
2
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Hit paper breakdown →
20171295
3 2003317
4
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study
Hit paper breakdown →
2022275
5 2001274
6 2016200
7 2004184
8 2011178
9 2006173
10 2015166
11 2003153
12 2019145
13 2016144
14 2021141
15 2014139
16 2021128
17 2020127
18 2009126
19 2015120
20 2015116

About Stephen J. Schuster

Stephen J. Schuster is a scholar working on Oncology, Pathology and Forensic Medicine, Genetics, Immunology and Hematology, having authored 376 papers that have together received 12.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (189 papers), CAR-T cell therapy research (161 papers), Chronic Lymphocytic Leukemia Research (103 papers), Viral-associated cancers and disorders (33 papers), Multiple Myeloma Research and Treatments (22 papers), Cutaneous lymphoproliferative disorders research (20 papers), Biosimilars and Bioanalytical Methods (20 papers) and Cancer Immunotherapy and Biomarkers (19 papers). The work is most often cited by research in Oncology (7.7k citations), Pathology and Forensic Medicine (4.3k citations), Genetics (1.8k citations), Immunology (2.6k citations) and Hematology (959 citations). Stephen J. Schuster has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Jakub Svoboda, Sunita D. Nasta, Elise A. Chong, Daniel J. Landsburg, David L. Porter, Edward A. Stadtmauer, Donald E. Tsai, Carl H. June, Simon F. Lacey and Philippe Armand. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, American Journal of Hematology and Hematological Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact